It is therefore conceivable that our EPN lines, enriched in stem-like cells, express a high MYCN/MYC ratio, that is switched by differentiation, similarly to what may occur in EPN specimens, where SCs represent only a restricted population of the tumor burden. This evidence concerns the gene MYC and neoplasm.